Neurobehavioral effects of prevalent toxicants in children

常见毒物对儿童神经行为的影响

基本信息

  • 批准号:
    6657529
  • 负责人:
  • 金额:
    $ 17.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-30 至 2003-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant) Epidemiologic and experimental data have established the adverse neurobehavioral effects of exposure in utero and during early childhood to numerous environmental toxicants, including lead, alcohol, mercury, PCB s, and environmental tobacco smoke (ETS). Still, the ideal biomarker for measuring in utero exposure to specific toxicants has not been established and the adverse effects of many potential neurotoxicants have not been rigorously tested. Fetal exposure is typically measured with self-reported surveys, maternal blood and urine, or cord blood. In contrast, meconium is a non-invasive method to simultaneously test for chronic exposures to numerous toxicants, but it is as yet unclear whether conventional biomarkers or meconium are more predictive of the adverse effects linked with specific toxicants. For lead exposure, emerging data indicate that our efforts should emphasize primary prevention, but the safety and efficacy of lead hazard controls are uncertain, especially for children with low blood lead concentrations. The investigators propose to conduct a longitudinal cohort study of 400 children, followed from less than 16 weeks gestation to 36 months of age, to examine the dose-response of low-level exposures (pre- and postnatal) to prevalent neurotoxicants with neurobehavioral outcomes and development disorders, such as conduct disorder, cognitive deficits, hearing loss and behaviors consistent with ADHD. The investigators will also conduct a nested, randomized controlled trial to test the efficacy of lead hazard controls or the development of adverse neurobehavioral effects. In Project 1 of University of California's Center Grant, the investigators will test the following hypotheses: 1) In utero exposures as measured by survey (alcohol and ETS), maternal and cord blood (lead, mercury, pesticides and ETS), and urine (pesticides) are less predictive of in utero effects of prevalent toxicants, such as cognition, behavioral problems, growth and hearing, compared with the same toxicants in meconium. 2) Postnatal exposures to pesticides, ETS and lead (at blood levels below 10 ug/dl) are associated with adverse neurobehavioral effects, growth delay and hearing loss in early childhood. 3) Children in the Lead Reduction Group will have blood lead levels that are 2.7 ug/dl (30%) or lower, significantly higher cognitive scores, less hearing loss, greater growth velocity, and fewer behavioral problems than the Control Group at 36 months of age. If funded, this project, combined with the specific aim of Project 2, to validate meconium as a marker of in utero exposure, will serve as a model to evaluate the adverse effects of exposures to multiple prevalent toxicants, validate meconium as a measure of in utero exposures to numerous toxicants, provide exposure and risk assessment data for residential pesticides, test an intervention for the primary prevention of subclinical lead toxicity, and test the efficacy of a lead hazard control on children?s blood lead concentration and neurobehavioral functioning.
描述(由申请人提供) 流行病学和实验数据已经确定了不利的 宫内和儿童早期接触铅对神经行为的影响 多种环境毒物,包括铅、酒精、汞、多氯联苯S和 环境烟草烟雾(ETS)。尽管如此,理想的生物标记物 在子宫内暴露于特定毒物的情况尚未确定, 许多潜在的神经毒物的不良反应还没有得到严格的研究 测试过。胎儿暴露通常是通过自我报告的调查来衡量的, 母血和尿液,或脐带血。相比之下,胎粪是一种非侵入性的 一种同时检测长期接触大量 毒物,但目前尚不清楚常规生物标志物或 胎粪更能预测与特定疾病相关的不良反应 毒药。对于铅暴露,新出现的数据表明,我们的努力应该 强调初级预防,但铅危害的安全性和有效性 控制是不确定的,特别是对低血铅儿童 浓度。研究人员建议进行纵向队列研究 对400名儿童的研究,随访时间从怀孕不到16周到36个月 年龄,以检查低水平暴露的剂量反应(前和 出生后)对普遍存在的神经毒物有神经行为后果和 发育障碍,如品行障碍、认知障碍、听力障碍 损失和行为符合ADHD。调查人员还将进行 一项检验铅危害疗效的嵌套式随机对照试验 控制或发展不良的神经行为影响。在项目1中 加州大学中心助学金的研究人员将测试 以下假设:1)通过调查测量的子宫内暴露(酒精和 母血和脐带血(铅、汞、杀虫剂和ETS)和尿液 (杀虫剂)对普遍存在的毒物的宫内影响预测较少, 如认知、行为问题、成长和听力,与 胎粪中含有相同的毒物。2)出生后暴露于杀虫剂、ETS和 铅(血液水平低于10ug/dl)与不良反应有关 儿童早期的神经行为影响、生长迟缓和听力损失。3) 减铅组的儿童血铅水平将为2.7 Ug/dl(30%)或更低,认知分数显著较高,听力较差 损失、更快的增长速度和更少的行为问题 36月龄组。 如果得到资助,该项目结合项目2的具体目标,将 验证胎粪作为宫内暴露的标志,将作为一种模式 评估接触多种流行毒物的不良影响, 确认胎粪作为宫内暴露于多种毒物的量度, 提供住宅用杀虫剂的暴露和风险评估数据、测试和 亚临床铅中毒一级预防干预措施及试验 儿童铅危害控制的效果--S血铅浓度 和神经行为功能。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRUCE P LANPHEAR其他文献

BRUCE P LANPHEAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRUCE P LANPHEAR', 18)}}的其他基金

Fluoride in Tooth Dentin and Neurodevelopmental Outcome in a Canadian Cohort
加拿大队列中牙齿牙本质中的氟化物和神经发育结果
  • 批准号:
    10176168
  • 财政年份:
    2019
  • 资助金额:
    $ 17.91万
  • 项目类别:
Fluoride in Tooth Dentin and Neurodevelopmental Outcome in a Canadian Cohort
加拿大队列中牙齿牙本质中的氟化物和神经发育结果
  • 批准号:
    10017974
  • 财政年份:
    2019
  • 资助金额:
    $ 17.91万
  • 项目类别:
Fluoride in Tooth Dentin and Neurodevelopmental Outcome in a Canadian Cohort
加拿大队列中牙齿牙本质中的氟化物和神经发育结果
  • 批准号:
    10434821
  • 财政年份:
    2019
  • 资助金额:
    $ 17.91万
  • 项目类别:
Fluoride in Tooth Dentin and Neurodevelopmental Outcome in a Canadian Cohort
加拿大队列中牙齿牙本质中的氟化物和神经发育结果
  • 批准号:
    10813234
  • 财政年份:
    2019
  • 资助金额:
    $ 17.91万
  • 项目类别:
A Community-Based Trial to Prevent Lead Poisoning and Injuries
预防铅中毒和伤害的社区试验
  • 批准号:
    7813987
  • 财政年份:
    2007
  • 资助金额:
    $ 17.91万
  • 项目类别:
A Community-Based Trial to Prevent Lead Poisoning and Injuries
预防铅中毒和伤害的社区试验
  • 批准号:
    7234588
  • 财政年份:
    2007
  • 资助金额:
    $ 17.91万
  • 项目类别:
A Community-Based Trial to Prevent Lead Poisoning and Injuries
预防铅中毒和伤害的社区试验
  • 批准号:
    7658278
  • 财政年份:
    2007
  • 资助金额:
    $ 17.91万
  • 项目类别:
A Community-Based Trial to Prevent Lead Poisoning and Injuries
预防铅中毒和伤害的社区试验
  • 批准号:
    7469574
  • 财政年份:
    2007
  • 资助金额:
    $ 17.91万
  • 项目类别:
Study of Prevalent Neurotoxicants in Children
儿童中常见神经毒物的研究
  • 批准号:
    6944281
  • 财政年份:
    2001
  • 资助金额:
    $ 17.91万
  • 项目类别:
Study of Prevalent Neurotoxicants in Children
儿童中常见神经毒物的研究
  • 批准号:
    7117509
  • 财政年份:
    2001
  • 资助金额:
    $ 17.91万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.91万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 17.91万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 17.91万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 17.91万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 17.91万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 17.91万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 17.91万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 17.91万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 17.91万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 17.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了